CLEVELAND, Sept. 26, 2023 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the Company has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval of EB-101, its…Original Article
You may also like
Orexo Submits New Drug Application to FDA for OX124, a...
Basilea Announces FDA Acceptance of New Drug...
FDA Issues Complete Response Letter for PDP-716 NDA...
Basilea Announces Submission of a New Drug Application...
Venatorx Pharmaceuticals Announces FDA Acceptance and...
Galera Receives Complete Response Letter from U.S. FDA...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.